Gene mutations, though they do not grant turtles the powers of the Teenage Mutant Ninja Turtles, play a crucial role in biology and medicine. They are small changes in DNA or RNA that arise during replication or cell division and can be either harmless or deleterious.
Gene mutations are alterations in nucleotides, genes, or chromosomes that can occur in germ cells (sperm and egg) or somatic cells (all other body cells). Germline mutations are heritable and can lead to inherited disorders, whereas somatic mutations are confined to the individual and can cause diseases such as cancer.
Most mutations arise just before or during cell division—mitosis or meiosis—when DNA replication or chromosomal segregation can go awry. Germline mutations are transmitted to offspring, while somatic mutations can increase the risk of cancer or lead to benign growths.
Mutations stem from spontaneous errors in DNA replication and repair, or from external mutagens such as toxic chemicals, ionizing radiation, and UV light. Carcinogens—mutagens that cause cancer—include UV radiation and certain industrial pollutants.
Gene mutations can be classified into several categories based on how the DNA sequence is altered:
These are changes affecting a single nucleotide and can be silent, missense, nonsense, or frameshift:
Duplications or amplifications of gene segments can increase gene dosage and expression. Gene amplification is implicated in cancers, such as breast cancer, and in genetic disorders like Fragile X syndrome, where expanded trinucleotide repeats destabilize DNA.
Large‑scale chromosomal alterations—deletions, duplications, inversions, translocations, and nondisjunction—can lead to developmental syndromes (e.g., Down syndrome, Turner syndrome, cri du chat syndrome) and cancers.
Identifying mutations early through prenatal testing and genetic screening informs family planning and disease management. Some carriers of disease‑associated mutations possess evolutionary advantages—sickle‑cell carriers are protected against malaria, and cystic‑fibrosis carriers may have resistance to cholera.